Biotech

All Articles

Novo inks $600M NanoVation bargain to study genetic medicines ex-liver

.Novo Nordisk is continuing its own push into genetic medications, agreeing to compensate NanoVation...

Innovent links cytokine to colon cancer actions

.Innovent Biologics has actually made the instance that its own gate inhibitor-cytokine combination ...

Merck, Daiichi ADC reaches target in phase 3 lung cancer study

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina grows artificial intelligence center along with collab to choose cancer targets

.Five months after Rakovina Therapies pivoted towards artificial intelligence, the cancer-focused bi...

Ascendis' dwarfism drug smash hits in stage 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a possible hazard to BioMarin's Voxzogo, stating phase 3 gr...

Despite ph. 3 skip, Alkeus sees path ahead for eye illness possession

.Though Alkeus Pharmaceuticals' dental eye disease asset stopped working to significantly reduce geo...

Kairos goes public with $6M IPO to cash trials of cancer cells drug

.Along with a triad of biotechs striking the Nasdaq on Friday, it was effortless to miss a smaller-s...

Vaccine and also Keytruda combo helpful in squamous tissue cancer

.Immune system checkpoint inhibitors are the superheroes of cancer cells therapy. Medicines like Bri...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, firings a...

Regeneron's Opdualag opponent presents 57% feedback price

.Regeneron is actually back along with long-lasting follow-up for its own LAG-3 inhibitor and PD-1 i...